ANAND MEHRA
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
SANTIAGO ARROYO, M.D., PH.D., CHARLES AUSTIN, ALAN BARBER, STEPHEN BLOCH, STEPHEN BLOCH, M.D., SCOTT BRAUNSTEIN, M.D., SCOTT BRAUNSTEIN, MD, ENRIQUE J. CARRAZANA, MD, CHRISTOPHER M. CASHMAN, MICHAEL R. DOUGHERTY, ELAN EZICKSON, SETH H.Z. FISCHER, ANTON GOPKA, JOSEPH HULIHAN, M.D., JOE HULIHAN, MD, JOHN KRAYACICH, MARTHA MANNING, ESQ., TIM M. MAYLEBEN, TIMOTHY MAYLEBEN, TIMOTHY M. MAYLEBEN, ANAND MEHRA, M.D., SARASWATHY NOCHUR, PH.D., HARRY PENNER, HARRY H. PENNER, JR., STEVEN E. PFANSTIEL, HARRY T. REIN, KENNETH SHAW, EDWARD F. SMITH, CABLE STUART, NICOLE VITULLO
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
KAMIL ALI-JACKSON, KEVIN BALTHASER, RICHARD A. BIERLY, ALBERT CHA, HUGH DAVIS, BRETT FAIR, DAVID GORDON, MAXINE GOWEN, WILLIAM HUMPHRIES, JAMES LOEROP, VINCENT MILANO, CHRISTOPHER MOLINEAUX, JOSEPH MONAHAN, KETAN PATEL, CHRISTOPHER POWALA, ANDREW POWELL, BRYAN REASONS, FRANK RUFFO, ANDREW SCHIFF, STUART SHANLER, STUART D. SHANLER, STEPHEN TULLMAN, STEPHEN A. TULLMAN, STEVEN A. TULLMAN, NEAL WALKER
DIRECTOR
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-11-19
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-03-30
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-12-20
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-08-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-02-15
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-08-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-01-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-06-02
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-08-28
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2014-09-08
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2012-12-07

